Janhavi Venkataraman

13PUBLICATIONS
0CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersClinical midwiferyCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 12, 2026
OneMark™ breast localisation: integrating diagnosis and surgical guidance-a narrative review.

|Aug 12, 2026
Targeted axillary dissection versus sentinel lymph node biopsy after neoadjuvant chemotherapy: are we underestimating the clinical significance of staging accuracy?

|Apr 27, 2026
Reconsidering the Interpretation of "Recurrence-Free Survival" After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89.

|Feb 23, 2026
Targeted Axillary Dissection Versus Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy: Why Staging Accuracy Matters.

Janhavi Venkataraman, Kefah Mokbel

|Sep 15, 2025
Reevaluating regional nodal irradiation after nodal pathologic complete response to neoadjuvant chemotherapy: toward individualized de-escalation.

Janhavi Venkataraman, Kefah Mokbel

|Aug 04, 2025
Key breast cancer highlights from the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.

Janhavi Venkataraman, Kefah Mokbel

Pageof 3

Frequent Collaborators